Carbamoyl phosphate

Summary

Carbamoyl phosphate is an anion of biochemical significance. In land-dwelling animals, it is an intermediary metabolite in nitrogen disposal through the urea cycle and the synthesis of pyrimidines. Its enzymatic counterpart, carbamoyl phosphate synthetase I (CPS I), interacts with a class of molecules called sirtuins, NAD dependent protein deacetylases, and ATP to form carbamoyl phosphate. CP then enters the urea cycle in which it reacts with ornithine (a process catalyzed by the enzyme ornithine transcarbamylase) to form citrulline.

Carbamoyl phosphate
Structural formula
Ball-and-stick model
Names
IUPAC name
(Carbamoyloxy)phosphonic acid
Identifiers
  • 590-55-6 checkY
3D model (JSmol)
  • Interactive image
ChEBI
  • CHEBI:17672 ☒N
ChEMBL
  • ChEMBL369105 ☒N
ChemSpider
  • 272 ☒N
ECHA InfoCard 100.230.975 Edit this at Wikidata
KEGG
  • C00169 ☒N
MeSH Carbamoyl+phosphate
  • 278
UNII
  • GC5KZW01Q3 checkY
  • InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)
    Key: FFQKYPRQEYGKAF-UHFFFAOYSA-N
  • C(=O)(N)OP(=O)(O)O
Properties
CH2NO5P2−
Molar mass 141.020 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

Classification edit

Carbamoyl phosphate is a metabolic intermediate in a pathway that involves nitrogen disposal through the urea cycle and the biosynthesis of pyrimidines.[1]

Production edit

It is produced from bicarbonate, ammonia (derived from amino acids), and phosphate (from ATP).[2] The synthesis is catalyzed by the enzyme carbamoyl phosphate synthetase.[2] This uses three reactions as follows:

  • HCO
    3
    + ATP → ADP + HO–C(O)–OPO2−
    3
    (carboxyl phosphate)
  • HO–C(O)–OPO2−
    3
    + NH3 + OHHPO2−
    4
    + O–C(O)NH2 + H2O
  • O–C(O)NH2 + ATP → ADP + H
    2
    NC(O)OPO2−
    3

Clinical significance edit

A defect in the CPS I enzyme, and a subsequent deficiency in the production of carbamoyl phosphate has been linked to hyperammonemia in humans.[3]

See also edit

References edit

  1. ^ Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A, Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML (1993). "Urea Cycle Disorders Overview". In Adam MP, Feldman J, Mirzaa GM, et al. (eds.). Gene Reviews. University of Washington, Seattle. PMID 20301396.
  2. ^ a b Bhagavan NV, Ha CE (2015). "Protein and Amino Acid Metabolism". In Bhagavan NV, Ha CE (eds.). Essentials of Medical Biochemistry (Second ed.). San Diego: Academic Press. pp. 227–268. doi:10.1016/b978-0-12-416687-5.00015-4. ISBN 978-0-12-416687-5.
  3. ^ Nakagawa T, Lomb DJ, Haigis MC, Guarente L (May 2009). "SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle". Cell. 137 (3): 560–570. doi:10.1016/j.cell.2009.02.026. PMC 2698666. PMID 19410549.

Further reading edit

  • Nelson DL, Cox MM (2005). Lehninger Principles of Biochemistry fourth edition. New York: W. H. Freeman and company. ISBN 978-0-7167-4339-2.